hum0074 Release Note

Click to Latest version.

Research IDRelease DateType of Data
hum0074.v1 2018/02/27 GWAS for patients with HCV infection (virologic response, platelet [PLT] reduction, and hemoglobin [Hb] reduction)

 

hum0074.v1

A genome-wide association studies for following symptoms were performed by using of Affymetrix Genome-Wide Human SNP Array 6.0.

(1) 78 null virologic response, 64 virologic response, and 51 sustained virologic response (43 SNPs)

(2) 107 HCV patients with decrease of PLT in response to PEG-IFN/RBV treatment and 196 HCV patients without decrease of PLT in response to PEG-IFN/RBV treatment (66 SNPs)

(3) 94 HCV patients with Hb reduction and 209 HCV patients without Hb reduction (32 SNPs)

 

Note: